Sen. Bob Menendez Robert (Bob) MenendezKasie Hunt to host lead-in show for MSNBC's 'Morning Joe' Senators ask for removal of tariffs on EU food, wine, spirits: report VOA visa decision could hobble Venezuela coverage MORE (D-N.J.) won reelection in New Jersey’s Senate race on Tuesday night, a huge relief for Democrats as he faced a tougher-than-expected challenge in the deep-blue state.

Menendez defeated Republican Bob Hugin, a former pharmaceutical company CEO, in race that became surprisingly tight over the summer.

ADVERTISEMENT

In 2015, Menendez was indicted on bribery and fraud charges for which he has denied any wrongdoing. His trial ended in a hung jury and federal prosecutors ultimately dropped the charges, but he was “severely admonished” by the Senate Ethics Committee.

With polls showing a close race and a lack of enthusiasm for Menendez in the primary, Hugin injected at least $31 million of his own money into his campaign. That forced national Democrats to make late ad buys to buoy Menendez, diverting resources from defending other incumbents in competitive races where President Trump Donald John TrumpOmar fires back at Trump over rally remarks: 'This is my country' Pelosi: Trump hurrying to fill SCOTUS seat so he can repeal ObamaCare Trump mocks Biden appearance, mask use ahead of first debate MORE was more popular.

Menendez framed Hugin, who served as the president's state campaign chairman in 2016, as a Trump acolyte. And as health care dominated the midterms, Menendez hewed closely to his work on the Affordable Care Act and hammered Hugin’s pharmaceutical company, Celgene Corp., for steeply raising the price of a cancer drug.

Menendez, the ranking member on the Senate Foreign Relations Committee, has served in the Senate since 2006 and has been in New Jersey politics for more than 30 years.